Company Filing History:
1 out of 156 
1 out of 832,843 Years Active: 1995-1997
Title: Joseph E Bugaj: Innovator in Therapeutic Radionuclide Compositions
Introduction
Joseph E Bugaj is a notable inventor based in Bothell, WA (US). He has made significant contributions to the field of therapeutic radionuclide compositions, holding a total of 2 patents. His work focuses on enhancing the stability and effectiveness of radionuclide compositions for medical applications.
Latest Patents
Joseph E Bugaj's latest patents include innovative methods for preparing stable therapeutic radionuclide compositions. These compositions comprise radionuclides such as .sup.186 Re, .sup.188 Re, and .sup.131 I, which are stably bound to a proteinaceous targeting moiety suitable for human in vivo administration. The patents disclose the use of stabilizing agents, preferably antioxidants and challenging agents, to enhance long-term stability. Notably, ascorbic acid is highlighted as a preferred stabilizing agent, providing stability levels of at least about 90% for several hours up to several days.
Career Highlights
Throughout his career, Joseph E Bugaj has worked with various organizations, including Neorx Corporation. His expertise in radionuclide compositions has positioned him as a key figure in the development of therapeutic solutions in the medical field.
Collaborations
Joseph has collaborated with notable professionals in his field, including Jean-Luc VanderHeyden and Alan R Fritzberg. These collaborations have contributed to the advancement of his research and innovations.
Conclusion
Joseph E Bugaj is a distinguished inventor whose work in therapeutic radionuclide compositions has the potential to significantly impact medical treatments. His innovative approaches and collaborations continue to pave the way for advancements in this critical area of healthcare.